SCHEMBL2196706

SCHEMBL2196706

CC(C)C[C@@H]([C]=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP8 Q6V1X1 2/20 0.43
DPP9 Q86TI2 2/20 0.43
DPP7 Q9UHL4 2/20 0.43
OPRK1 P41145 2/20 0.41
NPY4R P50391 8/20 0.40
NPY1R P25929 6/20 0.40
NPY2R P49146 5/20 0.40
NPY5R Q15761 4/20 0.40
GNAI3 P08754 1/20 0.40
GNAO1 P09471 1/20 0.40
GNAI1 P63096 1/20 0.40
DPP4 P27487 1/20 0.39
NMT2 O60551 1/20 0.37
NMT1 P30419 1/20 0.37
GSR P00390 1/20 0.37
GHSR Q92847 1/20 0.36
ERAP2 Q6P179 1/20 0.36
ERAP1 Q9NZ08 1/20 0.36
LNPEP Q9UIQ6 1/20 0.36
FURIN P09958 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2191184 1.00 DPP8 (0.43) DPP8DPP9DPP7OPRK1NPY4R
SCHEMBL2183569 1.00 DPP8 (0.43) DPP8DPP9DPP7OPRK1NPY4R
SCHEMBL2190396 0.97 NPY4R (0.43) DPP8DPP9DPP7OPRK1NPY4R
SCHEMBL1651538 0.93 DPP8 (0.48) DPP8DPP9DPP7GNAI3GNAO1
SCHEMBL1651541 0.93 DPP8 (0.48) DPP8DPP9DPP7GNAI3GNAO1
SCHEMBL2182926 0.93 OPRK1 (0.42) DPP8DPP9DPP7OPRK1NPY4R
SCHEMBL2182536 0.93 OPRK1 (0.42) DPP8DPP9DPP7OPRK1NPY4R
SCHEMBL2195069 0.93 OPRK1 (0.42) DPP8DPP9DPP7OPRK1NPY4R
SCHEMBL2182039 0.93 OPRK1 (0.42) DPP8DPP9DPP7OPRK1NPY4R
SCHEMBL28761909 0.93 NPY4R (0.43) DPP8DPP9DPP7OPRK1NPY4R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9173951-B2 Carbohydrate-based drug delivery polymers and conjugates thereof NEKTAR THERAPEUTICS (US) 2015-11-03 US disclosed
US-20150051371-A1 CARBOHYDRATE-BASED DRUG DELIVERY POLYMERS AND CONJUGATES THEREOF NEKTAR THERAPEUTICS (US) 2015-02-19 US disclosed
US-8680263-B2 Carbohydrate-based drug delivery polymers and conjugates thereof NEKTAR THERAPEUTICS (US) 2014-03-25 US disclosed
US-20110171716-A1 CARBOHYDRATE-BASED DRUG DELIVERY POLYMERS AND CONJUGATES THEREOF NEKTAR THERAPEUTICS (US) 2011-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110171716-A1 CARBOHYDRATE-BASED DRUG DELIVERY POLYMERS AND CONJUGATES THEREOF STT3B, STT3A, DDOST DPP8 274/4885DPP9 318/4885DPP7 218/4885
US-20150051371-A1 CARBOHYDRATE-BASED DRUG DELIVERY POLYMERS AND CONJUGATES THEREOF STT3B, STT3A, DDOST DPP8 274/4885DPP9 318/4885DPP7 218/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.